Express Scripts
Personalized Medicine in 2012: Industry Takes a Wait-and-See Approach Due to Market Unknowns
Premium
Roche made a splash last year with its repeated overtures to acquire genome sequencing firm Illumina, but for the most part, 2012 was a quiet year during which players in the life sciences industry took modest steps to increase their capabilities to advance personalized treatment
Third Rock Ventures has hired Felix Frueh as an entrepreneur-in-residence.
Originally published Aug. 23.
New Firm MetaDiagnostic Moves in to Help Dx Developers, Payors as PBMs Shift from Personalized Rx
Premium
Originally published Aug. 27.
Life Technologies to Compete in Archon Genomics X Prize
NEW YORK (GenomeWeb News) – Life Technologies has registered for the Archon Genomics X Prize, the X Prize Foundation said today.